Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophrenia

This study has been completed.
Information provided by (Responsible Party):
PharmaNeuroBoost N.V. Identifier:
First received: October 7, 2011
Last updated: November 18, 2014
Last verified: November 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)